Low-Density Lipoprotein Cholesterol Lowering Efficacy of Evolocumab May Reduce Need for Apheresis in Heterozygous Familial Hypercholesterolaemia Patients According to Russian Guidelines
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1769
https://www.valueinhealthjournal.com/article/S1098-3015(16)33135-7/fulltext
Title :
Low-Density Lipoprotein Cholesterol Lowering Efficacy of Evolocumab May Reduce Need for Apheresis in Heterozygous Familial Hypercholesterolaemia Patients According to Russian Guidelines
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33135-7&doi=10.1016/j.jval.2016.09.1769
First page :
A654
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1673